Thousands of autologous and at less extent allogeneic hematopoietic stem cells (HSC) bags are cryopreserved in France. The majority of autologous HSC grafts are used within a year after collection. However, many bags are still unused and cryopreserved for many years. In France and on a European scale, the ever-growing number of cryopreserved bags represents a real economic health concern. Indeed, the cost of storage is about 100 € per bag and per year. In addition, quality and therapeutic value of these long-term cryopreserved grafts needs to be evaluated. In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC) set up its ...
Background aims: Around 50 000 autologous stem cell transplantations are done each year worldwide us...
By 2003, 97% autologous transplants and 65% of allogeneic transplants in Europe used m...
Cell and gene therapies (CGT) are showing positive results in managing a range of healthcare challen...
International audienceThousands of autologous and at less extent allogeneic hematopoietic stem cells...
Background: Autologous stem cell transplantation (ASCT) requires collection and cryopreservation of ...
Background aims: Hematopoietic stem cell cryopreservation significantly contributed to autologous st...
Autologous peripheral blood stem cells transplantation (aPBSCT) is a therapeutic option that can be ...
There is considerable heterogeneity in manipulation and cryopreservation of hematopoietic stem cells...
Cryopreserved haematopoietic progenitor cells are used to restore autologous haematopoiesis after hi...
Autologous hematopoietic stem cells (HSCs) harvested as back-up prior to allogeneic hematopoietic SC...
If the field of regenerative medicine is to deliver therapies, rapid expansion and delivery over con...
Hematopoietic precursor cells (HPC) are able to restore hematopoiesis after high-dose chemotherapy a...
Background Traditionally, autologous BM or PBSC have been stored as a secondary source ('back-up') o...
Forty years ago, van Putten described in the European Journal of Cancer (see this issue) quantitativ...
Forty years ago, van Putten described in the European Journal of Cancer (see this issue) quantitativ...
Background aims: Around 50 000 autologous stem cell transplantations are done each year worldwide us...
By 2003, 97% autologous transplants and 65% of allogeneic transplants in Europe used m...
Cell and gene therapies (CGT) are showing positive results in managing a range of healthcare challen...
International audienceThousands of autologous and at less extent allogeneic hematopoietic stem cells...
Background: Autologous stem cell transplantation (ASCT) requires collection and cryopreservation of ...
Background aims: Hematopoietic stem cell cryopreservation significantly contributed to autologous st...
Autologous peripheral blood stem cells transplantation (aPBSCT) is a therapeutic option that can be ...
There is considerable heterogeneity in manipulation and cryopreservation of hematopoietic stem cells...
Cryopreserved haematopoietic progenitor cells are used to restore autologous haematopoiesis after hi...
Autologous hematopoietic stem cells (HSCs) harvested as back-up prior to allogeneic hematopoietic SC...
If the field of regenerative medicine is to deliver therapies, rapid expansion and delivery over con...
Hematopoietic precursor cells (HPC) are able to restore hematopoiesis after high-dose chemotherapy a...
Background Traditionally, autologous BM or PBSC have been stored as a secondary source ('back-up') o...
Forty years ago, van Putten described in the European Journal of Cancer (see this issue) quantitativ...
Forty years ago, van Putten described in the European Journal of Cancer (see this issue) quantitativ...
Background aims: Around 50 000 autologous stem cell transplantations are done each year worldwide us...
By 2003, 97% autologous transplants and 65% of allogeneic transplants in Europe used m...
Cell and gene therapies (CGT) are showing positive results in managing a range of healthcare challen...